Keith Robison

Keith Robison is a distinguished computational biologist with extensive experience in both academic and industry settings. Currently serving as an Advisory Board Member for Medical & Molecular Sciences at the University of Delaware and as a Principal Scientist at Ginkgo Bioworks, Robison has played key roles at various biotech companies, including Day Zero Diagnostics as a SAB Member and previously at Warp Drive Bio and Infinity Pharmaceuticals as a Principal Scientist and Lead Senior Scientist, respectively. With a robust academic background, including a PhD in Molecular & Cellular Biology from Harvard University, Robison is known for contributions to genomics, synthetic biology, and oncology therapeutics, along with well-regarded commentary in the field through the Omics! Omics! blog.